DE2548053A1 - Azazyklische verbindungen - Google Patents

Azazyklische verbindungen

Info

Publication number
DE2548053A1
DE2548053A1 DE19752548053 DE2548053A DE2548053A1 DE 2548053 A1 DE2548053 A1 DE 2548053A1 DE 19752548053 DE19752548053 DE 19752548053 DE 2548053 A DE2548053 A DE 2548053A DE 2548053 A1 DE2548053 A1 DE 2548053A1
Authority
DE
Germany
Prior art keywords
group
benzhydryl
compound
compounds
azetidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752548053
Other languages
German (de)
English (en)
Inventor
Elijah H Gold
Daniel M Solomon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DE2548053A1 publication Critical patent/DE2548053A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
DE19752548053 1974-10-30 1975-10-27 Azazyklische verbindungen Pending DE2548053A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51939674A 1974-10-30 1974-10-30

Publications (1)

Publication Number Publication Date
DE2548053A1 true DE2548053A1 (de) 1976-05-06

Family

ID=24068150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752548053 Pending DE2548053A1 (de) 1974-10-30 1975-10-27 Azazyklische verbindungen

Country Status (14)

Country Link
JP (1) JPS51125273A (enExample)
AU (1) AU8606075A (enExample)
BE (1) BE834928A (enExample)
DE (1) DE2548053A1 (enExample)
DK (1) DK482775A (enExample)
FI (1) FI753006A7 (enExample)
FR (1) FR2289185A1 (enExample)
GB (1) GB1517934A (enExample)
IL (1) IL48369A0 (enExample)
LU (1) LU73660A1 (enExample)
NL (1) NL7512541A (enExample)
NO (1) NO753594L (enExample)
SE (1) SE7512066L (enExample)
ZA (1) ZA756740B (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4173566A (en) * 1974-10-30 1979-11-06 Schering Corporation 1-Benzhydryl-2-cyanoazetidine
EP0025880A1 (en) * 1979-08-24 1981-04-01 Takeda Chemical Industries, Ltd. Azetidine derivative, its production, the derivative for use as an anti-obesity agent
WO2020188301A1 (en) * 2019-03-20 2020-09-24 Atrogi Ab Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia
US11357757B2 (en) 2017-09-13 2022-06-14 Atrogi Ab Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
US11427539B2 (en) 2017-09-13 2022-08-30 Atrogi Ab Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
US11648216B2 (en) 2017-09-13 2023-05-16 Atrogi Ab Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
US11793774B2 (en) 2017-09-13 2023-10-24 Atrogi Ab Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
US12378216B2 (en) 2019-03-20 2025-08-05 Atrogi Ab Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198449A (en) * 1990-04-27 1993-03-30 A. H. Robins Company Incorporated N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173566A (en) * 1974-10-30 1979-11-06 Schering Corporation 1-Benzhydryl-2-cyanoazetidine
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
EP0025880A1 (en) * 1979-08-24 1981-04-01 Takeda Chemical Industries, Ltd. Azetidine derivative, its production, the derivative for use as an anti-obesity agent
US11357757B2 (en) 2017-09-13 2022-06-14 Atrogi Ab Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
US11427539B2 (en) 2017-09-13 2022-08-30 Atrogi Ab Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
US11648216B2 (en) 2017-09-13 2023-05-16 Atrogi Ab Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
US11793774B2 (en) 2017-09-13 2023-10-24 Atrogi Ab Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
US12036210B2 (en) 2017-09-13 2024-07-16 Atrogi Ab Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
US12280023B2 (en) 2017-09-13 2025-04-22 Atrogi Ab Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
WO2020188301A1 (en) * 2019-03-20 2020-09-24 Atrogi Ab Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia
US12378216B2 (en) 2019-03-20 2025-08-05 Atrogi Ab Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia

Also Published As

Publication number Publication date
FI753006A7 (enExample) 1976-05-01
NO753594L (enExample) 1976-05-03
IL48369A0 (en) 1975-12-31
FR2289185A1 (fr) 1976-05-28
LU73660A1 (enExample) 1976-08-19
NL7512541A (nl) 1976-05-04
GB1517934A (en) 1978-07-19
JPS51125273A (en) 1976-11-01
ZA756740B (en) 1976-10-27
DK482775A (da) 1976-05-01
AU8606075A (en) 1977-05-05
BE834928A (fr) 1976-04-28
SE7512066L (sv) 1976-05-03

Similar Documents

Publication Publication Date Title
DE1964516C3 (de) 1-Substituierte 3-Propionyl-anilinopyrrolidine, Verfahren zu ihrer Herstellung und Arzneimittel
DE2411382B2 (de) 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
DE2929517A1 (de) Pinenderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
DE2143204C3 (de) N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE2437610A1 (de) Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DD150457A5 (de) Verfahren zur herstellung der(r,r)optisch isomeren verbindungen von labetalol
DE2952213A1 (de) Phenoxyphenylpiperidine
DE69426835T2 (de) Derivate von 2-arylalkenyl-azacyclo alkan als sigma rezeptor-liganden, verfahren zu ihrer herstellung und ihrer therapeutischer anwendung
DE2548053A1 (de) Azazyklische verbindungen
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE60002733T2 (de) Diester prodrugs von decahydroischinoline-3-carbonsäure
CH631164A5 (de) Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin.
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
DE3402060A1 (de) Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69103087T2 (de) N-substituierte Trifluormethylphenyltetrahydropyridine, Verfahren zur Herstellung, Zwischenprodukte, sowie Arzneimittel, die solche enthalten.
DE1964515A1 (de) 1-Substituierte-4-Phenoxypiperidine und Verfahren zu ihrer Herstellung
EP0002672B1 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2017256A1 (de) l-Carbamoyl-3-pheny!pyrrolidine und Verfahren zu deren Herstellung
DE2434693A1 (de) 1,4-disubstituierte piperidine
DE2708110A1 (de) Pyrrolbenzoxaaza-alkane
DE2653147C2 (enExample)
CH638184A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DE3000625A1 (de) Cis- und trans-isomere von 3-aryloxy- 4-hydroxypyrrolidinen und deren derivaten, verfahren zu ihrer herstellung und ihre verwendung
US4052383A (en) N-diphenylalkyl-2-benzyl azacyclic compounds
US4140780A (en) Pharmaceutical compositions comprising N-diphenylalkyl-2-benzyl azacyclic compounds and methods for their use

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee